You are here: Industry Insights > Ebola

News List

NIH begins testing Ebola treatment in early-stage trial europeanpharmaceuticalreview
May 30, 2018
Scientists developed monoclonal antibody from Ebola survivor…
Congo begins Ebola vaccination biospectrumasia
May 22, 2018
The World Health Organization, which called the risk of the disease spreading "very high," is sending the country 7,540 doses of the vaccine developed by Merck.
High doses of favipiravir may be effective against Ebola europeanpharmaceuticalreview
March 29, 2018
High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study….
National Research Council contribution plays key role in newly approved Ebola vaccine biospace
March 21, 2018
In response to the Ebola outbreak that claimed more than 10,000 lives in West Africa four years ago, Canada and China worked on a new Ebola vaccine
German researchers conduct a new study on Ebola biospectrumasia
January 02, 2018
By switching off PP2A-B56, the virus' ability to copy itself and produce more infection can be inhibited.
China approves domestic Ebola vaccine biospectrumasia
October 27, 2017
The newly approved vaccine is superior to the currently available vaccines in terms of the stability.
Trials reveal two strong vaccine candidates for Ebola pharmafile
October 17, 2017
Two clinical-stage vaccine candidates for Ebola have produced stunning results, not least because an unexpected protection emerged.
Research team discovers epithelial cells in eyes can prevent spread of Ebola pharmaceutical-technology
July 20, 2017
A team of researchers from Flinders University, CSIRO and Emory University have discovered a super cell in the eye that might have the potential to contain the virus responsible for the spread of Ebola.
Response to Merck's Ebola vaccine lasts at least a year, study finds fiercepharma
June 14, 2017
In a phase 3 trial in West Africa, Merck’s Ebola vaccine rVSV-ZEBOV has already shown it can elicit a quick immune response. Now, a new study in the U.S. found that the vaccine's protective qualities can last for at least a year.
Merck's experimental Ebola vaccine poised for emergency use in Congo outbreak fiercepharma
June 01, 2017
The Democratic Republic of the Congo has given initial approval for the emergency use of Merck’s as-yet-unlicensed Ebola shot to combat a local outbreak, and medical providers are putting together plans for administering it.

Previous page 1 2 3 4 5 6 7 Next page